Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/11/2017
SIETES contiene 92128 citas

 
 
 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA 2017;318:1679-86. [Ref.ID 102138]
2. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
3. Cita con resumen
Anónimo. NICE OKs Remicade for Crohn's. Scrip 2002;2744/45:5. [Ref.ID 61731]
4. Cita con resumen
Gardiner SJ, Begg EJ, Barclay ML, Kirkpatrick CMJ. Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine. Adverse Drug React Toxicol Rev 2000;19:293-312. [Ref.ID 53946]
5. Cita con resumen
Anónimo. Allopurinol and azathioprine. Interaction. Australia. WHO Pharmaceuticals Newsletter 2000;2:8. [Ref.ID 53155]
6.
Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-15. [Ref.ID 39978]
7.
Lewis LD, Benin A, Szumlanski CL, Otterness DM, Lennard L, Weinshilboum RM, Nierenberg D W. Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction. Clin Pharmacol Ther 1997;62:464-75. [Ref.ID 36140]
8. Cita con resumen
Lilleyman JS, Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 1994;343:1188-90. [Ref.ID 21855]
9.
Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992;43:329-39. [Ref.ID 18287]
Seleccionar todas
 
 1 a 9 de 9